Eternity Healthcare Signs Letter of Intent to License Technologies from Kinexus Theranostics, for a Kinases Based Diagnostic Test for Early Detection of Diabetes.

Phoenix, AZ and Vancouver, BC – April 15, 2014  Eternity Healthcare Inc. (OTC: ETAH), a leading medical device and diagnostic company with special focus on diabetes management, announced today that has signed a Letter of Intent (LOI) to license technologies from...

Eternity Healthcare to Initiate a Large Scale Clinical Trial of its Needle-Free Injection System in Patients Undergoing Fertility Treatments using the drug Gonadotropins

Phoenix, AZ, and Vancouver, BC. – March 17, 2014- Eternity Healthcare Inc. (OTCBB:ETAH), a medical device and diagnostic company announced today that they have signed an agreement with a major fertility clinic Pacific Center for Reproductive Medicine. Eternity...

Eternity Healthcare terminates Letter of Intent (LOI) with Global Medical Equipment of America (GMEA)

Phoenix, AZ, and Vancouver, BC – February 28, 2014 — Eternity Healthcare Inc. (OTCBB:ETAH), or the “Company”, a medical device and diagnostic company announced today that it has terminated the  Letter of Intent (LOI) agreement with Phoenix-based Global...